Literature DB >> 25827177

Patients undergoing elective coronary artery bypass grafting exhibit poor pre-operative intakes of fruit, vegetables, dietary fibre, fish and vitamin D.

B Ruiz-Núñez1, G H A M van den Hurk1, J H M de Vries2, M A Mariani3, M J L de Jongste3, D A J Dijck-Brouwer1, F A J Muskiet1.   

Abstract

CHD may ensue from chronic systemic low-grade inflammation. Diet is a modifiable risk factor for both, and its optimisation may reduce post-operative mortality, atrial fibrillation and cognitive decline. In the present study, we investigated the usual dietary intakes of patients undergoing elective coronary artery bypass grafting (CABG), emphasising on food groups and nutrients with putative roles in the inflammatory/anti-inflammatory balance. From November 2012 to April 2013, we approached ninety-three consecutive patients (80% men) undergoing elective CABG. Of these, fifty-five were finally included (84% men, median age 69 years; range 46-84 years). The median BMI was 27 (range 18-36) kg/m(2). The dietary intake items were fruits (median 181 g/d; range 0-433 g/d), vegetables (median 115 g/d; range 0-303 g/d), dietary fibre (median 22 g/d; range 9-45 g/d), EPA+DHA (median 0.14 g/d; range 0.01-1.06 g/d), vitamin D (median 4.9 μg/d; range 1.9-11.2 μg/d), saturated fat (median 13.1% of energy (E%); range 9-23 E%) and linoleic acid (LA; median 6.3 E%; range 1.9-11.3 E%). The percentages of patients with dietary intakes below recommendations were 62% (fruits; recommendation 200 g/d), 87 % (vegetables; recommendation 150-200 g/d), 73% (dietary fibre; recommendation 30-45 g/d), 91% (EPA+DHA; recommendation 0.45 g/d), 98% (vitamin D; recommendation 10-20 μg/d) and 13% (LA; recommendation 5-10 E%). The percentages of patients with dietary intakes above recommendations were 95% (saturated fat; recommendation < 10 E%) and 7% (LA). The dietary intakes of patients proved comparable with the average nutritional intake of the age- and sex-matched healthy Dutch population. These unbalanced pre-operative diets may put them at risk of unfavourable surgical outcomes, since they promote a pro-inflammatory state. We conclude that there is an urgent need for intervention trials aiming at rapid improvement of their diets to reduce peri-operative risks.

Entities:  

Keywords:  Coronary artery bypass grafting surgery; Coronary artery disease; Diets; Low-grade inflammation

Mesh:

Substances:

Year:  2015        PMID: 25827177     DOI: 10.1017/S0007114515000434

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  4 in total

1.  The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study.

Authors:  Karla Santo; Karice Hyun; Laura de Keizer; Aravinda Thiagalingam; Graham S Hillis; John Chalmers; Julie Redfern; Clara K Chow
Journal:  Int J Behav Nutr Phys Act       Date:  2018-05-23       Impact factor: 6.457

2.  Heart Rehabilitation in patients awaiting Open heart surgery targeting to prevent Complications and to improve Quality of life (Heart-ROCQ): study protocol for a prospective, randomised, open, blinded endpoint (PROBE) trial.

Authors:  Johanneke Hartog; Fredrike Blokzijl; Sandra Dijkstra; Mike J L DeJongste; Michiel F Reneman; Willem Dieperink; Iwan C C van der Horst; Joke Fleer; Lucas H V van der Woude; Pim van der Harst; Massimo A Mariani
Journal:  BMJ Open       Date:  2019-09-18       Impact factor: 2.692

3.  Food Taste, Dietary Consumption, and Food Preference Perception of Changes Following Bariatric Surgery in the Saudi Population: A Cross-Sectional Study.

Authors:  Nora A Althumiri; Mada H Basyouni; Faisal Saeed Al-Qahtani; Mohammed Zamakhshary; Nasser F BinDhim
Journal:  Nutrients       Date:  2021-09-27       Impact factor: 5.717

4.  Atrial fibrillation after cardiac surgery and preoperative vitamin D levels: A systematic review and meta-analysis.

Authors:  Selen Öztürk; İbrahim Öztürk
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-01-23       Impact factor: 0.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.